Home › Funds › Nan Fung Group Holdings Ltd › MPLT
Nan Fung Group Holdings Ltd position in MPLT
MAPLIGHT THERAPEUTICS INC · Health Care
Nan Fung Group Holdings Ltd reported holding 2,300,328 shares of MPLT (MAPLIGHT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$23.4M, representing 15.84% of its reported portfolio and ranking #2 among its reported holdings. Nan Fung Group Holdings Ltd has disclosed MPLT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Nan Fung Group Holdings Ltd's MPLT position evolved
Nan Fung Group Holdings Ltd first disclosed a stake in MPLT in Q4 2025 at 971,253 shares (US$17.1M). The position peaked in Q2 2026 at 971,253 shares, worth US$34.8M. Across 4 filings, Nan Fung Group Holdings Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 2,300,328 shares valued at US$23.4M — an increase of 1,329,075 shares quarter over quarter.. Notable position changes include a 137% increase in Q3 2026 (shares fell 29% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 971.25K | $17.06M | New |
| Q1 2026 | 971.25K | $19.75M | Hold |
| Q2 2026 | 971.25K | $34.81M | Hold |
| Q3 2026 | 2.30M | $23.44M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MPLT and 13F data
MPLT (MAPLIGHT THERAPEUTICS INC) is a Health Care company. 97 other funds we track also report a position in MPLT — the largest reported positions include Novo Holdings A/S (US$132.1M), FCPM III SERVICES B.V. (US$115.6M), 5AM Venture Management, LLC (US$34.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MPLT
- Novo Holdings A/S 3.69M sh · $132.13M · Q2 2026
- FCPM III SERVICES B.V. 3.23M sh · $115.63M · Q2 2026
- 5AM Venture Management, LLC 950.01K sh · $34.05M · Q2 2026
- Paradigm Biocapital Advisors LP 685.85K sh · $24.58M · Q2 2026
- Velan Capital Investment Management LP 492.89K sh · $17.67M · Q2 2026
- Sanofi 912.04K sh · $9.29M · Q3 2026
- Pivotal bioVenture Partners Investment Advisor LLC 611.45K sh · $6.23M · Q3 2026
- DAFNA Capital Management LLC 171.01K sh · $6.13M · Q2 2026
- Blue Owl Capital Holdings LP 556.37K sh · $5.67M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 125.43K sh · $4.50M · Q2 2026
- STEMPOINT CAPITAL LP 106.91K sh · $3.83M · Q2 2026
More on Nan Fung Group Holdings Ltd
FAQ
How long has Nan Fung Group Holdings Ltd held MPLT?
Nan Fung Group Holdings Ltd has disclosed MPLT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Nan Fung Group Holdings Ltd's current position in MPLT?
As of Q3 2026, Nan Fung Group Holdings Ltd holds 2.30M shares of MPLT (MAPLIGHT THERAPEUTICS INC), valued at $23.44M, representing 15.84% of its reported portfolio and ranking #2.
Has Nan Fung Group Holdings Ltd been buying or selling MPLT?
In the latest 13F filing (Q3 2026), Nan Fung Group Holdings Ltd increased its position in MPLT. The position peaked in Q2 2026 at 971.25K shares.
Which other funds hold MPLT?
Other major institutional holders of MPLT include Novo Holdings A/S, FCPM III SERVICES B.V., 5AM Venture Management, LLC, among 97 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.